Surface Oncology CEO J Goater's 2018 pay jumps 236% to $4.7M
Surface Oncology reports 2018 executive compensation
By ExecPay News
Published: April 19, 2019
Surface Oncology reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, three executives at Surface Oncology received on average a compensation package of $2.2M, a 159% increase compared to previous year.
Average pay of disclosed executives at Surface Oncology
J. Jeffrey Goater, Chief Executive Officer, received $4.7M in total, which increased by 236% compared to 2017. 86% of Goater's compensation, or $4.1M, was in option awards. Goater also received $220K in non-equity incentive plan, $429K in salary, as well as $10K in other compensation.
Vito J. Palombella, Chief Scientific Officer, received a compensation package of $979K, which increased by 46% compared to previous year. 48% of the compensation package, or $474K, was in option awards.
Robert W. Ross, Chief Medical Officer, earned $880K in 2018, a 88% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2019.